Search

Resoundant to Exhibit at AASLD Annual Meeting 2016


For the fourth year, Resoundant, Inc. will be exhibiting at the annual meeting of the American Association for the Study of Liver Diseases (AASLD), also known as The Liver Meeting®, being held on November 11 — 15, 2016, at the John B. Hynes Veterans Memorial Convention Center, Boston.

"We truly appreciate the outstanding work of the AASLD, and look forward to returning to The Liver Meeting® this November," said Richard L. Ehman, MD, CEO of Resoundant, Inc.

"For us, this meeting is a wonderful opportunity to learn directly from leading Hepatologists about how we can better serve both them and their patients. The field of Hepatology is moving at a rapid pace, with clinicians leveraging huge amounts of clinical and laboratory information to develop the most personalized care plans possible. We believe that MR Elastography can greatly assist Hepatology practices by giving clinicians and their patients the most complete and accurate liver diagnostics available - allowing Hepatologists to more closely monitor treatment effectiveness and giving patients a completely painless new option [as opposed to liver biopsy]."

Resoundant, Inc. will be exhibiting at Booth #708, where attendees can learn more about how liver MR Elastography can benefit their patients. Attendees can also visit www.resoundant.com/aasld for more information on Resoundant's presence at The Liver Meeting® 2016.

Papers and Posters at The Liver Meeting® on MR Elastography (link)

42 Prospective Comparison to Liver Biopsy of VCTE/CAP, MRE, PDFF, and Multiparametric MRI for Predicting Degree of Steatosis and Diagnosis of NASH

Katharine K. Roberts1, Induruwa N. Pathirana1, Angelo H. Paredes1, Christopher J. Lisanti2, Ryan Schwope2, Katherine M. Cebe3, Jennifer M. Aldridge-Whitehead2, James K. Aden4, Stephen A. Harrison1; 1Gastroenterology, Brooke Army Medical Center, Fort Sam Houston, TX; 2Radiology, Brooke Army Medical Center, Fort Sam Houston, TX; 3Pathology, Brooke Army Medical Center, Fort Sam Houston, TX; 4Biomedical Statistics, Institute for Surgical Research, Fort Sam Houston, TX

220 MR Elastography reliably predicts presence and absence of cirrhosis for different etiologies of chronic liver disease

Akash Shukla, Sudheer Pargewar, Ashlesha Udare, Swati Kamble, Prashant Dhore, Mihir Vora, Parijat A. Gupte, Samir R. Shah; Institute of liver disease, HPB surgery and transplantation, Global Hospital, Mumbai, India

649 Combined MR elastography and collagen molecular MR imaging accurately stage liver fibrosis in a rat model

Bo Zhu1,2, Lan Wei3, Helen Day1, Tyson Rietz1, Christian T. Farrar1, Gregory Y. Lauwers4, Kenneth K. Tanabe3, Bruce Rosen1, Bryan C. Fuchs3, Peter Caravan1; 1Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Cambridge, MA; 2Physics, Harvard University, Cambridge, MA; 3Surgical Oncology, Massachusetts General Hospital, Boston, MA; 4Pathology, Massachusetts General Hospital, Boston, MA

1110 The Presence and Severity of Coronary Artery Disease in Patients with Biopsy-Proven NAFLD: A Prospective Prevalence Study

Kelvin N. Bush2, Ryan I. Prentice2, Emilio Fentanes2, Richard W. Hilliard2, Christopher J. Lisanti3, Ryan Schwope3, Katherine M. Cebe4, Pedro A. Manibusan1, Angelo H. Paredes1, James K. Aden5, James Watts2, Dustin M. Thomas2, Stephen A. Harrison1; 1Gastroenterology, Brooke Army Medical Center, Fort Sam Houston, TX; 2Cardiology, Brooke Army Medical Center, Fort Sam Houston, TX; 3Radiology, Brooke Army Medical Center, Fort Sam Houston, TX; 4Pathology, Brooke Army Medical Center, Fort Sam Houston, TX; 5Biomedical Statistics, Institute for Surgical Research, Fort Sam Houston, TX

1151 Baseline patient characteristics and non-invasive image analysis in a Phase 2 therapeutic trial of GR-MD-02 in NASH patients with stage 3 fibrosis

Stephen A. Harrison1, Karol Barstow1, Adam E. Allgood2, Peter G. Traber2; 1Gastroenterology, Brooke Army Medical Center, Fort Sam Houston, TX; 2Galectin Therapeutics, Norcross, GA

About Resoundant, Inc.

Resoundant, Inc is a medical technology company dedicated to improving patient care and diagnosis accuracy by making Magnetic Resonance Elastography (MRE) available around the world. We are based in Rochester, MN and were founded by Mayo Foundation for Medical Education & Research, Mayo Clinic physicians and researchers.

For more information, go to: www.resoundant.com/aasld

#Liver #AASLD #TheLiverMeeting

+1 507-322-0011

© 2020 by Resoundant, Inc.

421 1st Ave SW STE 204W

Rochester, MN

55902, United States

  • Black Facebook Icon
  • Black Twitter Icon
  • Black LinkedIn Icon